Andreas Hoff and Peter Eide awarded Masters degree
Congratulations to Andreas Hoff and Peter Eide, who defended their Masters theses on the 17th and 21st of June 2011 respectively at the Institute for Molecular Biosciences, University of Oslo.
Panagopoulos I, Stranger A, Sveen A, Jareid M, Kidd SG, Bischof K, Taskén K, Dørum A, Davidson B, Lothe RA, Skotheim RI, Johannessen B(2026) Fusion gene heterogeneity and kinase enrichment in high-grade serous carcinomas Neoplasia, 79, 101332(in press) DOI 10.1016/j.neo.2026.101332, PubMed 42349107
Kryeziu K, Klokkerud SK, Totland MZ, Moosavi SH, Reims HM, Bergsland CH, Eilertsen IA, Smeby J, Lassen K, Lundesgaard KK, Syversveen T, Brændengen M, Nesbakken A, Guren TK, Yaqub S, Sveen A, Lothe RA(2026) Patient-derived organoids from metastatic colorectal cancer mirror tumor heterogeneity and predict patient survival and drug sensitivity Cell Rep Med, 7(6), 102840 DOI 10.1016/j.xcrm.2026.102840, PubMed 42208542
Ailte I, Chauhan SK, Prasmickaite L, Bassarova AV, Poissonnier A, Feenstra M, Nyakas M, Johannessen B, Ryder T, Hermann R, Frich L, Holth A, Inderberg EM, Jespersen H, Flørenes VA, Kyte JA, Mælandsmo GM, Egeland EV(2026) CD38hiCD19dim cells in lymph nodes predict favorable prognosis in patients with stage III melanoma receiving adjuvant PD-1-blockade Front Oncol, 16, 1815008 DOI 10.3389/fonc.2026.1815008, PubMed 42158424
